Linus Health, a digital health company focused on early detection of Alzheimer’s and other dementias, is set to have a significant presence at the American Academy of Family Physicians’ (AAFP) FMX 2024 conference in Phoenix.

The company is introducing new tools designed to assist primary care physicians (PCPs) in efficiently screening for dementia, aiming to reduce unnecessary referrals to neurologists.

These tools include four FDA-listed digital neuropsychological tests and five new questionnaires, which will help PCPs accurately identify patients with dementia or mild cognitive impairment (MCI). By using these tools, PCPs will be better equipped to take timely action, supported by Linus Health’s clinical decision aids. Conference attendees can learn more and see a demo at the Linus Health booth (#1742).

John Showalter, MD, MSIS, chief strategy officer of Linus Health, will also present a Med Talk at FMX '24, discussing the role of family physicians in early detection of cognitive impairment.

His talk will focus on how PCPs can incorporate digital tools into routine screenings for MCI, highlighting how early detection can lead to interventions that delay or prevent the onset of dementia. The talk is scheduled for September 26 at The Xchange: Med Talk Booth 1905.

Linus Health’s new tools are designed to support PCPs, who are often the first to diagnose dementia in patients. With a growing shortage of neurologists and long wait times for specialist appointments, these tools will help PCPs take a more central role in dementia care.

By providing more accurate screening at the primary care level, these tools will reduce the burden on neurologists while ensuring timely care for patients.

Linus Health is working with neurospecialists to develop customized workflows that integrate the new digital assessments into primary care, memory clinics, or specialist visits. The four voice- and speech-powered assessments are based on established neuropsychological tests, typically administered in person or on paper.

These include tasks such as naming animals within a time limit and recalling words. The five questionnaires help determine the underlying cause of cognitive impairment, whether it’s MCI, dementia, or conditions like depression or anxiety. Results can be shared with neurologists when necessary, streamlining the referral process.

Earlier identification of MCI allows PCPs to offer patients personalized Brain Health Action Plans, which may include lifestyle changes such as exercise, improved sleep, diet modifications, and mental activities that can slow or prevent the progression of dementia.

By equipping primary care providers with these early detection tools, Linus Health aims to reduce the strain on dementia specialists and improve patient outcomes. Early intervention has the potential to prevent or delay more than half of dementia cases, providing a significant opportunity for better management of this growing health concern. Additionally, using these assessments will facilitate reimbursement for dementia screening services, further supporting PCPs in offering these critical evaluations.

 

Source: linushealth.com

Report Abuse